Prevalence of nicotine pouch use found to be low among U.S. adults

FHS
July 11, 2024
6:48 pm

A new study found that the prevalence of nicotine pouch use was low in U.S. adults despite a 641% increase in sales of the products between 2019 and 2022.

BMS expands Krazati’s FDA label to include colorectal cancer

BMS added Krazati to its portfolio when it acquired Mirati Therapeutics for $5.8bn. Credit: Katherine Welles/Shutterstock. The US Food and Drug Administration (FDA) has approved

June 24, 2024

US FDA approves Amneal’s 505(b)(2) NDA for PEMRYDI RTU

PEMRYDI RTU will be offered in 500 mg/50mL, 100mg/10mL and 1,000mg/100mL vial sizes. Credit: MasterTux from Pixabay. The US Food and Drug Administration (FDA) has

June 15, 2023

Religious Psychedelics Groups and 501(c)(3) Status: An Update

Section 501(c)(3) of the Internal Revenue Code provides tax exemptions for qualifying charitable organizations, like religious groups. Naturally, religious groups that use psychedelics want 501(c)(3) status.

June 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.